Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Non-Prescription Drugs

          

Consumer Self-Care Americas (Csca)

269.31Cr 292.59Cr 296.23Cr 269.37Cr 258.53Cr

Total Assets

598.38Cr 513.41Cr 495.29Cr 468.76Cr 349.14Cr

CAPEX

-11Cr -6.81Cr -6.64Cr -8.45Cr -5.8Cr

Gross Profit

77Cr 79Cr 91Cr 78Cr 75Cr

D&A

12Cr 12Cr 13Cr 14Cr 15Cr

Operating Income

21Cr 37Cr 39Cr 27Cr -67Cr

Consumer Self-Care International(Csci)

144.56Cr 152.57Cr 169.33Cr 167.96Cr 166.77Cr

Total Assets

442.58Cr 588.32Cr 585.62Cr 496.01Cr 504.38Cr

CAPEX

-2.4Cr -2.62Cr -3.53Cr -3.38Cr -3.54Cr

Gross Profit

65Cr 67Cr 77Cr 76Cr 74Cr

D&A

18Cr 22Cr 23Cr 19Cr 18Cr

Operating Income

3.61Cr -3Cr -3.52Cr 10Cr -23Cr

Dental Care Products

          

All Other

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Pharmaceutical Products

          

Prescription Pharmaceuticals (rx)

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Total Assets

- - - - -

Operating Income

- - - - -

Total Assets

1.61Cr - - - -

Operating Income

17Cr -26Cr -20Cr -26Cr -22Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States (U.S.)

256.59Cr 287Cr 291.68Cr 264.93Cr 254.01Cr

Total Assets

67Cr 73Cr 72Cr 72Cr 67Cr

Total Assets

- - - - -

Europe (Excl. Ireland)

136.93Cr 144.5Cr 158.17Cr 156.5Cr 157.42Cr

Total Assets

17Cr 19Cr 18Cr 20Cr 22Cr

All Other Countries

18Cr 11Cr 12Cr 12Cr 9.67Cr

Total Assets

1.48Cr 1.27Cr 1.15Cr 1L 2L

Ireland

2.37Cr 2.93Cr 4.08Cr 3.96Cr 4.21Cr

Total Assets

1L - 2L 17L 35L